tiprankstipranks
Tnf Pharmaceuticals, Inc. (TNFA)
:TNFA
US Market

TNF Pharmaceuticals (TNFA) Financial Statements

Compare
550 Followers

TNF Pharmaceuticals Financial Overview

TNF Pharmaceuticals's market cap is currently $1.32M. The company's EPS TTM is $-13.728; its P/E ratio is ―; TNF Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ -29.45K$ -74.06K
Operating Income$ -17.12M$ -15.28M$ -28.20M$ -12.29M$ -3.40M
EBITDA$ -4.00M$ 0.00$ -29.28M$ -12.12M$ -3.31M
Net Income$ -4.00M$ -15.20M$ -29.89M$ -17.58M$ -3.89M
Balance Sheet
Cash & Short-Term Investments$ 4.92M$ 4.84M$ 11.56M$ 35.34M$ 9.68M
Total Assets$ 17.86M$ 17.54M$ 24.81M$ 36.84M$ 10.88M
Total Debt$ 48.87K$ 141.72K$ 149.15K$ 4.13M$ 1.00M
Net Debt$ -2.63M$ -607.37K$ -406.82K$ -14.49M$ 487.49K
Total Liabilities$ 5.09M$ 2.84M$ 1.17M$ 2.26M$ 1.53M
Stockholders' Equity$ 12.77M$ 14.70M$ 23.65M$ 34.58M$ 9.36M
Cash Flow
Free Cash Flow$ -12.98M$ -12.27M$ -19.52M$ -11.92M$ -3.07M
Operating Cash Flow$ -12.98M$ -12.27M$ -19.52M$ -11.92M$ -3.07M
Investing Cash Flow$ 1.85M$ 6.91M$ 19.85M$ -8.76M$ -3.94M
Financing Cash Flow$ 13.07M$ 5.55M$ 73.53K$ 38.67M$ 6.97M
Currency in USD

TNF Pharmaceuticals Earnings and Revenue History

TNF Pharmaceuticals Debt to Assets

TNF Pharmaceuticals Cash Flow

TNF Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis